Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) — Free Cash Flow Generation Index
Latest as of September 2025:
1.00x
Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) has a Free Cash Flow Generation Index of 1.00x as of September 2025. Free cash flow of $137.90K represents 1% of operating cash flow ($137.91K). See Drugs Made In America Acquisition Corp. short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
1.00x
Free Cash Flow / Operating CF
Free Cash Flow
$137.90K
USD
Operating Cash Flow
$137.91K
USD
Capital Expenditures
$4.00
USD
Annual Free Cash Flow Generation for Drugs Made In America Acquisition Corp. Ordinary Shares (None–None)
Year-by-year Free Cash Flow Generation Index for Drugs Made In America Acquisition Corp. Ordinary Shares. For the full company profile including market capitalisation, see Drugs Made In America Acquisition Corp. market cap and net worth.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).